Guardant Health, Inc. (GH) Competitors & Peers
The 5 largest companies in the same industry as Guardant Health, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| TMO | Peer | $651.45 | P/E 35.2RSI 68Cap 241.2 B |
| DHR | Peer | $210.93 | P/E 37.9RSI 57Cap 149.0 B |
| NTRA | Peer | $361.85 | RSI 70Cap 52.1 B |
| IQV | Peer | $266.40 | P/E 33.6RSI 67Cap 44.5 B |
| A | Peer | $155.88 | P/E 30.8RSI 62Cap 44.0 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- EXASCompetitor
Cologuard + Guardant SHIELD compete in CRC screening.
Model-inferred, unverified — treat as a lead, not evidence - GRALCompetitor
Competes in liquid biopsy oncology screening and multi-cancer detection bids.
Model-inferred, unverified — treat as a lead, not evidence - ONCCompetitor
Both compete in precision diagnostics and biomarker-guided therapies.
Model-inferred, unverified — treat as a lead, not evidence